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Ventilatory inefficiencyThe prognostic value of exercise oscillatory breathing (EOB) during cardiopulmonary test (CPX) has been
described in young chronic heart failure (HF) patients. We assessed the prognostic role of EOB vs other clinical
and ventilatory parameters in elderly HF patients performing a maximal CPX.
Methods and results: We prospectively followed-up 370 HF outpatients ≥65 years after a symptom limited
CPX. We tested the predictive value of clinical and ventilatory parameters for all-cause mortality and a
composite of all-cause mortality and HF hospitalizations. Median age was 74 years, 51% had ischemic heart
disease, 25% NYHA class III; ejection fraction was 41% [34–50]. Peak oxygen consumption (PVO2) was 11.9
[9.9–14] mL/kg/min, the slope of the regression line relating ventilation to CO2 output, (VE/VCO2 slope) was
33.9 [29.8–39.2]. EOB was found in 58% of patients. At follow-up, 84 patients died and overall 158, using a
time-to-first event approach, met the composite end-point. Independent predictors of all-cause mortality
were CPX EOB and the ratio of VE/VCO2 slope to peak VO2, hemoglobin, creatinine and body mass index. The
area under the ROC curve (AUC) of the Cox multivariable model was 0.80 (95% CI 0.73 to 0.87). Independent
predictors of the composite end-point were EOB, VE/VCO2 slope, hemoglobin and HF admissions in the
previous year (Model AUC 0.75) (95% CI 0.69 to 0.81).
Conclusions: Among elderly HF patients, EOB prevalence is higher than middle-aged cohorts. EOB and the
ratio of VE/VCO2 slope to peak VO2 resulted the strongest ventilatory predictor of all-cause mortality,
independent of ventricular function.. Spirito Hospital, Lungotevere
39 3388479212.
.
Ltd. All rights reserved.© 2011 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Prognostic stratification of patients with chronic heart failure (HF)
is useful for follow-up planning and for tailoring therapeutic
interventions [1]. The elderly HF population is markedly heteroge-
neous. Many elderly HF patients are frail with multiple comorbidities
and for them the only realistic aim is to relieve symptoms and
improve quality of life. However a substantial proportion of these
patients, without significant comorbidities or exercise limitations,
fully qualify for management and prognostic stratification similar to
those routinely used for younger patients [2].
Cardiopulmonary exercise test (CPX) provides simultaneous
assessment of the performance of the heart, lungs, muscles andcellular respiration during physical exercise. Accordingly, CPX has an
established role in the identification of patients with exercise
intolerance at higher risk for major cardiac events [3]. Although
guidelines advocate the test to select heart transplant candidates and
to distinguish between respiratory or cardiac limitations [4], CPX use
and application are now beyond this role, providing prognostic and
functional information in the whole spectrum of HF severity [3,4]. In
particular, CPX can be an important risk stratification tool even in
elderly HF patients who cannot be considered for heart transplant,
provided that they are physically able to perform a maximal exercise
test [2]. We previously demonstrated [5] that even in the elderly the
test is safe, feasible and reliable in terms of prognostic stratification.
Classification into high, intermediate and low risk may substan-
tially improve delivery of health services, as patients should receive
care at the level best suited to their individual needs. Low-risk
patients may be routinely managed in primary care, whereas patients
at intermediate risk should receive strict follow-up by cardiologists
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at high risk with a poor short term outlook advanced treatment
options may be futile, and the focus of care should be on symptom
relief.
In a recent study conducted on a range of patients of a suitable age
for heart transplantation, ventilatory efficiency assessed by the
minute ventilation/carbon dioxide production (VE/VCO2) slope
during CPX, allowed to develop a reliable risk stratification system
for a wide range of HF patients with different severity stages [6].
Exercise oscillatory ventilation (EOB), a cyclic breathing pattern of
oscillations in minute ventilation and gas exchange kinetics during
incremental exercise, has been suggested to represent a stronger
predictor than VE/VCO2 slope [7]. EOB often co-exists with central
sleep apnea and may reflect a more severe derangement of the
ventilatory control system [8]. Furthermore, recent findings support
the usefulness of EOB in predicting death from arrhythmic causes [9].
The relative prognostic role of VE/VCO2 slope and EOB has not yet
been fully elucidated in the elderly HF population. Our aim was to
assess the prognostic value of ventilatory variables for all-cause
mortality and a composite of mortality and hospitalization for HF.
2. Methods
Elderly (≥65 years) patients with a clinical diagnosis of HF [1] consecutively
evaluated at the CPX laboratories of Santo Spirito Hospital, Rome, and San Paolo
Hospital, Milan, Italy between March 1993 and June 2008 were enrolled in this study.
The indication to CPX was clinical decision-making for follow-up planning and tailored
medical or electrical treatment. Exclusion criteria were : 1) mitral stenosis or previous
mitral valve surgery 2) severe aortic stenosis (peak systolic velocity ≥4.5 m/s) or
severe aortic insufficiency 3) significant pulmonary or liver disease 4) recent
(≤3 months) myocardial infarction 5) New York Heart Association (NYHA) functional
class IV 6) clinical limitations to exercise (orthopedic problems, severe peripheral
vascular disease, complex arrhythmias, history of recent syncope or unstable angina,
high degree atrio-ventricular block, severe anemia, severe hyperthyroidism, and
resting blood pressure ≥220/120 mm Hg) and 7) worsening symptoms or need for
intravenous inotropic support during the last 4 weeks.
Patients were in NYHA classes I–III on stable drug doses since at least 3 months and
able to perform a CPX test with a respiratory exchange ratio (RER) N1.00, indicating the
achievement of anaerobic exercise conditions, and with a peak oxygen uptake (PVO2)
b25 mg/kg/min. Among 545 elderly HF patients, 370 were enrolled, while 135 (27%)
were excluded according to the inclusion/exclusion criteria and 25 (5%) were excluded
for sub-maximal exercise (RERb1). Baseline laboratory assessment (brain natriuretic
peptide (BNP), hemoglobin, serum sodium and serum creatinine) was performed
according to standard laboratory methods.
All consecutive subjects who met the entry criteria were enrolled and tracked after
CPX. All patients received routine follow-up care at the two participating institutions.
Outcome data of patients who did not attend their scheduled appointments (b10% of
those enrolled) were obtained by telephone interview of the patient or his/her family;
none of these patients had been admitted to a hospital. All subjects signed a written
informed consent, and institutional review board approval was obtained at each
institution.
2.1. CPX procedure and data collection
The same equipment and exercise testing protocol was used in both participating
centers. Symptom-limited CPX was performed by cycle ergometry ramping, analysis
was performed with a metabolic cart (SensorMedics Vmax29, Yorba Linda, Calif).
Before each test, the equipment was calibrated in standard fashion with reference
gases. Standard 12-lead ECGs were obtained at rest, each minute during exercise, and
for at least 5 min during the recovery phase. Blood pressure was measured with a
standard cuff sphygmomanometer. Minute ventilation (VE), oxygen uptake (VO2),
carbon dioxide output (VCO2), and other cardiopulmonary variables were acquired on
a breath-by-breath basis and averaged over 10-second intervals. PVO2 and peak
respiratory exchange ratio was expressed as the highest averaged samples obtained
during the exercise test. VE and VCO2 values were acquired from the initiation of
exercise to peak exercise. For the calculation of VE/VCO2 slope linear relationship, we
measured all data points from the beginning to the end of exercise, in agreement with
what was recently demonstrated [10]. The ratio of VE/VCO2 slope to PVO2, previously
suggested as a better predictor of prognosis than either variable alone [11] was also
analyzed.
EOB was assessed with the criteria previously reported by Leite et al. [12] and
defined as 1) 3 or more regular oscillatory fluctuations in VE; 2) minimal average
amplitude of ventilatory oscillation of 5 L (peak value minus the average of two in-
between consecutive nadirs); and 3) a regular oscillation as defined by an SD of 3
consecutive cycle lengths (time between two consecutive nadirs) within 20% of the
average. A RERN1.00 was selected for the definition of maximal exercise.2.2. Doppler echocardiography
Left ventricular ejection fraction (LVEF) was measured according to the modified
Simpson's biplane method. Mitral peak early (E) and late (A) wave flow velocity and
the E/A ratio were determined by pulsed-wave Doppler echocardiography [13].
2.3. Statistical analysis
Categorical variables are presented as frequency percents and continuous variables
as median values [interquartile range]. Between-group differences according to EOB
were tested by chi-square test and Student's t-test or non parametric testing according
to normal or non normal variable distribution.
Study end-points were all-cause mortality and a combination of all-cause mortality
or hospital admission for worsening HF. To determine the independent predictors of
outcome, we entered variables significant by univariable analysis (pb0.10) in
multivariable Cox proportional hazards models that identified relevant covariates
through a forward selection procedure. Hazard ratios (HR) are presented with 95%
confidence intervals (CI). Non categorical variables were entered as continuous values
and HR are expressed as risk per 1 unit change. Model discrimination was tested using
the c statistic and expressed as area under the ROC curve (AUC).
A p valueb0.05 was considered statistically significant. All statistical tests were
two-tailed. Data were analyzed using The Statistical Package for the Social Sciences
SPSS 10.
3. Results
3.1. Study population
Clinical characteristics and CPX parameters of the 370 elderly
stable HF outpatients included in this study are summarized in
Table 1. Patients were studied after optimization of drug therapy beta-
blockers (carvedilol, mean dose 18±6 mg) in 227 (61%), and RAS-
inhibitors in 340 (92%). Cardiac resynchronization therapy and a
cardioverter defibrillator had been implanted in 21 patients (5.6%).
EOB was found in 215 patients (58%). EOB was significantly
associated to male gender (63% of men and 45% of women had EOB,
pb0.001), an HF admission in the previous year (66% of patients with
and 46% of those without a recent HF admission had EOB, pb0.001),
and a lower median LVEF (40% in patients with vs 45% in those
without EOB, pb0.001).
3.2. Prediction of outcome
During amedian tracking period of 29 [12–47] months, 84 patients
died (51 of worsening HF, 17 of sudden death, 1 of acute myocardial
infarction, 2 of stroke, 1 of pulmonary embolism, 10 of cancer, and 1 of
respiratory failure); 90 subjects were admitted for worsening HF.
Using a time-to-first event approach, overall 158 patients met the
combined end-point of all-cause mortality or HF admission. Variables
significantly associated to all-cause mortality and to the combined
endpoint by univariable analysis are reported in Tables 2 and 3. By
multivariable analysis, EOB predicted both all-cause mortality and the
combined end point, independently of ventricular function (Table 4).
The adjusted hazard curves for all-cause mortality or the combined
end point for patients with or without EOB are shown in Figs. 1 and 2,
respectively. Model AUC was 0.80 (95% CI 0.73 to 0.87) for all-cause
mortality and 0.75 (95% CI 0.69 to 0.81) for the composite end-point
(Figs. 3 and 4).
4. Discussion
To the best of our knowledge, this is the first study to specifically
assess the incidence of EOB in an elderly HF population, and to
describe its relationship with other ventilatory abnormalities during
CPX and its prognostic impact. We found that EOB is much more
common in aged HF patients (58%) than previously reported in
younger populations (20–30%) [7–9,14]. Still, in agreement with
previous data [7–9,14] on middle aged HF patients, EOB emerged as
the strongest independent CPX predictor of survival even in our
elderly series.
Table 1
Clinical characteristics and main parameters in the 370 study patients.
Female gender 107 (29%)
Ischemic etiology 190 (51%)
NYHA class III 92 (25%)
Age (years) 74 [71–78]
BMI 25.4 [23.1–27.7]
Sodium mmol/L 140 [138–141]
Creatinine mg/dL 1.22 [1.0–1.5]
Hemoglobin g/L 14 [13.8–14.1]
BNP pg/mL 152 [86–400]
HF admissions in the previous year 199 (54%)
Atrial fibrillation 51 (14%)
Permanent pacemaker 29 (8%)
Left ventricular ejection fraction (%) 41 [34–50]
E/A ratio 0.85 [0.61–1.47]
RER 1.10 [1.02–1.19]
Workload (W) 64 [48–81]
PVO2 (mL/kg/min) 11.9 [9.9–14]
% PVO2 61 [50–75]
VE/VCO2 slope 33.9 [29.8–39.2]
VE/VCO2 slope/PVO2 2.8 [2.19–3.72]
EOB 215 (58%)
Data are presented as median [interquartile range] or numbers (%). A, Transmitral A
Velocity; BMI, body mass index; BNP, brain natriuretic peptide; LVEF, left ventricular
ejection fraction; E, Transmitral E Velocity; EOB, exercise oscillatory breathing; PVO2,
peak oxygen uptake;% PVO2, percent predicted PVO2; RER, respiratory exchange ratio;
VE, ventilation; VE/VCO2 slope, slope of the regression line relating VE to carbon dioxide
production; and VO2AT, oxygen uptake at anaerobic threshold.
Table 3
Univariable predictors of all cause death and HF admission.
Chi-square P HR 95% CI
HF admission previous 12 months 26.883 b0.001 2.753 1.847–4.105
Hemoglobin g/dL 16.672 b0.001 0.776 0.688–0.876
BNP pg/mL 16.183 b0.001 1.001 1.000–1.001
EOB 15.026 b0.001 1.945 1.381–2.74
Workload (W) 11.662 0.001 0.989 0.983–0.995
NYHA class III vs I–II 11.301 0.001 1.788 1.268–2.522
PVO2 (mL/Kg/min) 9.863 0.001 0.929 0.889–0.972
VE/VCO2 slope 8.426 0.004 1.04 1.008–1.041
VE/VCO2 slope/PVO2 6.994 0.009 1.1 1.025–1.182
LVEF (%) 6.37 0.012 0.983 0.971–0.996
E/A ratio 5.975 0.015 1.158 1.028–1.304
Age 3.395 0.066 1.029 0.998–1.06
% PVO2 3.385 0.064 0.992 0.985–1.00
Creatinine mg/dL 2.961 0.083 1.278 0.968–1.687
Body mass index 1.306 0.253 0.975 0.934–1.018
Sodium mmol/L 0.995 0.318 0.977 0.934–1.022
Beta-blockers 0.498 0.481 1.123 0.814–1.549
Atrial fibrillation 0.285 0.594 1.195 0.622–2.294
Female gender 0.139 0.709 0.934 0.654–1.335
Ischemic etiology 0.004 0.952 1.01 0.737–1.384
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few studies have focused on the role of CPX for risk stratification in
this specific population or analyzed the prognostic value of ventilatory
variables in patients of an age similar to those enrolled in our study
[15–17]. Both Davies et al. [15] and Mejhert et al. [16] reported a
powerful predictive role of VE/VCO2 slope in a small series of HF
patients. However, their analyses were restricted to patients with
systolic heart failure. In a larger study by Cicoira et al. [17], both PVO2
and VE/VCO2 slope were mortality predictors. In our previous report
[18] in 331 consecutive outpatients aged N70 years with mild to
moderate congestive HF and both impaired and preserved systolic
functions, we found that a reduced glomerular filtration rate and a
steeper VE/VCO2 slope provide additional independent prognostic
information across the spectrum of ventricular function impairment
and help to identify high risk patients better than BNP and LVEF. In
396 elderly (N65 years) HF patients, Parikh et al. [19] demonstrated
that PVO2 and the Heart Failure Survival Score were both excellentTable 2
Univariable predictors of all cause death.
Chi-square P HR 95% CI
Hemoglobin g/dL 39.538 b0.001 0.597 0.509–0.699
BNP pg/mL 19.88 b0.001 1.001 1.001–1.001
EOB 14.625 b0.001 2.26 1.569–4.375
NYHA class III vs I–II 11.464 0.001 2.116 1.358–3.298
LVEF (%) 11.459 0.001 0.968 0.950–0.987
Creatinine mg/dL 10.696 0.001 1.657 1.229–2.234
VE/VCO2 slope 10.557 0.001 1.035 1.014–1.057
Sodium mmol/L 7.922 0.005 0.93 0.885–0.978
HF admission previous 12 months 7.844 b0.001 2.19 1.248–3.844
E/A ratio 6.63 0.011 1.207 1.044–1.395
Body mass index 6.429 0.011 0.92 0.862–0.981
Workload (W) 5.998 0.014 0.989 0.981–0.998
VE/VCO2 slope/PVO2 5.605 0.019 1.128 1.020–1.248
PVO2 (mL/kg/min) 5.52 0.017 0.924 0.865–0.986
Age 4.751 0.03 1.045 1.004–1.087
Ischemic etiology 1.786 0.183 1.348 0.869–2.092
% PVO2 1.006 0.314 0.994 0.983–1.006
Beta-blockers 0.241 0.624 0.897 0.582–1.384
Female gender 0.091 0.764 0.928 0.569–1.512predictors of survival. Remarkably, in these studies EOB was not
included in the final analysis.
In the present series, we could confirm that all-cause mortality for
HF patients over 65 years is high, even in a stable outpatient
population. By univariable analysis, common prognostic indicators
such as age, NYHA class, LVEF, BNP, hemoglobin, a HF admission in the
previous 12 months as well as most CPX variables, were associated to
both mortality and HF readmissions (Tables 2 and 3). However, only
the ventilatory variables EOB, VE/VCO2 slope and its ratio to PVO2,
together with parameters indicative of clinical deterioration (hemo-
globin, creatinine, and body mass index) retained an independent
prognostic validity by multivariable analysis, independent of the level
of systolic function. PVO2 per se was not independently predictive
either of all-cause mortality or of the combined end-point. Conversely
among CPX variables, a number of previous reports found that VE/
VCO2 slope/VO2 and EOB are better prognostic predictors than PVO2
[6,7,11,14].
The proposed pathogenetic mechanisms of EOB are multiple and
include low cardiac output and the consequent increase in lung to
chemoreceptor circulation time, a delayed response in the negative
feedback loop that modulates ventilation and blood gas tension;
impaired ventilatory control resulting in excessive ventilation due to
an increased chemoreceptor sensitivity and/or to elevated LV filling
pressure; and interstitial pulmonary edema with stimulation of vagal
irritant receptors [7–9]. Data on the prevalence and quantification of
EOB across various HF populations are not conclusive. In previous
studies in middle-aged male patient cohorts [7–9,14] the prevalence
of EOB ranged from 12% to 35%. In the only study conducted inTable 4
Independent predictors of outcome by multivariable analysis.
Chi-square P HR 95% CI
All-cause death
Hemoglobin 24.898 0.0001 0.640 0.538–0.763
VE/VCO2 slope/PVO2 10.180 0.001 1.269 1.096–1.468
EOB 8.987 0.003 2.641 1.400–4.983
Creatinine 7.707 0.005 1.725 1.174–2.535
Body mass index 4.403 0.036 0.918 0.887–0.984
All-cause death+HF admissions
HF admission previous 12 months 12.503 0.001 2.281 1.441–3.603
Hemoglobin 7.621 0.006 0.832 0.331–0.948
EOB 7.016 0.008 1.772 1.160–2.707
VE/VCO2 slope 6.600 0.01 1.027 1.006–1.049
Fig. 1. Hazard function for all-cause mortality, adjusted by the other independent
predictors of outcome, according to presence or absence of exercise oscillatory breathing
(EOB).
Fig. 3. ROC curve of the multivariable Cox model for all-cause mortality (AUC, area
under the curve; CI confidence interval).
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similar to the one observed in subjects with systolic dysfunction.
The prevalence of EOB has never been explored in elderly HF
patients. Our study is the first to assess this phenomenon in a “real
world” elderly HF population, as demonstrated by the relatively high
prevalence of female gender and high median LVEF. We observed EOB
in a proportion of patients (58%) near double compared with the
prevalence in younger subjects, potential heart transplant candidates
[7–9,14]. Although we cannot fully explain the reasons for this high
EOB prevalence in the elderly, the loss of elastic recoil of the chest wall
due to the aging process might substantially contribute to the
exacerbation of an oscillatory breathing pattern during exercise.
4.1. Clinical implications
The coexistence of EOB and ventilatory inefficiency identifies a
population with severe circulatory and ventilatory instability, that
carries a heavier burden of adverse events than conferred by any
single ventilatory abnormality. Medical management for these
patients should be reviewed and optimized whenever possible:
beta-blockade [20] as well as ACE-inhibitors [21] has been shown to
significantly reduce the VE/VCO2 slope, while their effects on EOB are
not known; tailored up-titration should also be considered. AerobicFig. 2. Hazard function for the combined end point of all-cause mortality and admission
for heart failure, adjusted by the other independent predictors of outcome, according to
presence or absence of exercise oscillatory breathing (EOB).exercise training has likewise the potential to improve prognosis by
reducing VE/VCO2 slope [22]. Strict clinical follow-up should be
envisaged to recognize early clinical signs of impending destabiliza-
tion and to institute appropriate changes in treatment. Cardiac
resynchronization therapy has been shown to significantly reduce
the VE/VCO2 slope and should be considered for high risk subjects,
after optimized medical management.
4.2. Study limitations
Our study population was relatively small and included only
clinically stable “robust” outpatients with mild to moderate HF, who
did not have important comorbidities and were furthermore able to
perform a CPX.Fig. 4. ROC curve of the multivariable Cox model for all-cause mortality and admission
for heart failure (AUC, area under the curve; CI confidence interval).
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that triggers and sustains EOB in elderly HF population. Nonetheless,
the observed high EOB prevalence suggests that further studies are
desirable in order to quantify EOB relevance in HF populations with
more advanced disease stages.
We did not perform serial CPX to investigate whether some
patients developed EOB during the follow-up and to assess the impact
of optimized treatment on it. This is certainly an important point to
address in future investigations.
In conclusion, an EOB pattern is remarkably frequent in elderly HF
patients and represents a key marker of adverse outcome. These
findings prospect the utility of comprehensively assessing CPX-
derived information to optimize the clinical and prognostic workup
of elderly HF patients.
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